Progeria
Progeria, also known as Hutchinson-Gilford syndrome and Werner's syndrome, is a rare genetic disorder characterized by symptoms resembling premature aging. There are two main forms: Hutchinson-Gilford syndrome (HGPS), which manifests in infancy, and Werner's syndrome, which typically develops in late adolescence to early adulthood. HGPS is caused by mutations in a key protein within the cell nucleus, leading to symptoms such as deteriorating skin, baldness, and a host of vascular diseases, significantly shortening life expectancy to a median age of thirteen. In contrast, Werner's syndrome presents with symptoms that include short stature, cataracts, and increased risks of diabetes and heart disease, with life expectancy extending into the mid-forties.
Both forms are marked by chronic and progressive health issues, yet they are not merely examples of accelerated aging, as certain bodily functions remain relatively unaffected. While no cure currently exists, treatments focus on supportive therapies, including antioxidant supplements, growth hormone therapy, and potential gene therapy, aimed at alleviating symptoms and improving quality of life. The Progeria Research Foundation highlights that as of December 2023, there are approximately 144 children worldwide diagnosed with HGPS, reflecting the ongoing need for research and understanding of these complex conditions.
Progeria
ALSO KNOWN AS: Hutchinson-Gilford syndrome, Werner’s syndrome
ANATOMY OR SYSTEM AFFECTED: All
DEFINITION: A rare disorder characterized by many aspects of premature aging
CAUSES: Genetic mutation
SYMPTOMS: Superficial aspects of aging including deteriorated skin, baldness, repeated nonhealing fractures, vascular diseases; also short stature, thin extremities, squeaky voice, cataracts, increased risk of diabetes, heart disease, tumors, hearing loss, bone and tooth loss
DURATION: Chronic and progressive
TREATMENTS: Supportive therapy, including antioxidant supplements (e.g., vitamin E), growth hormones, gene therapy
Causes and Symptoms
There are two major, unrelated types of progeria: Hutchinson-Gilford syndrome, which begins in infancy, and Werner’s syndrome, which develops in late adolescence to young adulthood. Recessive inheritance has been demonstrated for Werner’s syndrome, whereas a dominant gene is a suspected source in Hutchinson-Gilford syndrome. Underlying causes have been difficult to determine, although an impaired ability to cope with free radicals appears to play a role in the degenerative course found in each disease.
Hutchinson-Gilford syndrome is characterized by superficial aspects of such as deteriorated skin, baldness, repeated nonhealing fractures, and diseases, in addition to short stature and minimal fat. Arteriosclerosis and heart disease lead to a median age of death of thirteen. Werner’s syndrome occurs more frequently, with the following symptoms: short stature, thin extremities, a squeaky voice, cataracts, an increased risk of diabetes mellitus, heart disease, tumors, hearing loss, and the loss of bone and teeth. Death usually occurs by the middle forties. Neither disorder is simply accelerated aging. For example, the is relatively unaffected in both diseases.
Treatment and Therapy
No known cure exists for progeria diseases. Suggested treatments include antioxidant supplements (for example, vitamin E), growth hormone therapy, and gene therapy. Therapies have focused on providing a supportive environment and treating the symptoms to make the disorders less painful. Among these treatments are surgery, skin (if skin ulceration occurs), and drugs.
Perspective and Prospects
Hutchinson-Gilford syndrome was first described by Jonathan Hutchinson in 1886. Hastings Gilford named the disorder progeria in a 1904 article. The first cases of Werner’s syndrome were reported in the 1950s.
There are hopes for an eventual genetic solution to progeria diseases. The only definitive prospect for sufferers, however, is death. The Progeria Research Foundation estimates that there were 144 children known to be living with Hutchinson-Gilford Progeria Syndrome worldwide as of December 2023.
Bibliography
Judd, Sandra J., ed. Genetic Disorders Sourcebook: Basic Consumer Information About Heritable Disorders. 4th ed. Detroit, Mich.: Omnigraphics, 2010.
Gormley, Myra Vanderpool. Family Diseases: Are You at Risk? Baltimore: Genealogical Publishing, 2002.
Parker, James N., and Philip M. Parker, eds. Progeria: A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. San Diego, Calif.: Icon Health, 2004.
Lewin, Benjamin. Genes. 9th rev. ed. Sudbury, Mass.: Jones and Bartlett, 2008.
Lewis, Ricki. Human Genetics: Concepts and Applications. 10th ed. Dubuque, Iowa: McGraw-Hill, 2012.
"Meet the Kids & Young Adults." Progeria Research Foundation, 2023, www.progeriaresearch.org/meet-the-kids/. Accessed 8 Apr. 2024.
Milunsky, Aubrey. Heredity and Your Family’s Health. Baltimore: Johns Hopkins University Press, 1992.
"Progeria." MedlinePlus, 18 Sept. 2023, medlineplus.gov/ency/article/001657.htm. Accessed 8 Apr. 2024.
Worm, Cecilie, et al. "Defining the Progeria Phenome." Aging, vol. 16, no. 3, 2024, pp. 2026-2046. DOI: 10.18632/aging.205537. Accessed 8 Apr. 2024.